These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 8383767)
21. Identification and characterization of all-trans-retinoic acid receptor transcripts and receptor protein in human neuroblastoma cells. Clagett-Dame M; Verhalen TJ; Biedler JL; Repa JJ Arch Biochem Biophys; 1993 Feb; 300(2):684-93. PubMed ID: 8382032 [TBL] [Abstract][Full Text] [Related]
22. Response and resistance to retinoic acid are mediated through the retinoic acid nuclear receptor gamma in human teratocarcinomas. Moasser MM; DeBlasio A; Dmitrovsky E Oncogene; 1994 Mar; 9(3):833-40. PubMed ID: 8108126 [TBL] [Abstract][Full Text] [Related]
23. Down-regulation of retinoic acid receptor activity associated with decreased alpha and gamma isoforms expression in F9 embryonal carcinoma cells differentiated by retinoic acid. Lazega D; Schenker E; Busso N; Zelent A; Chen A; Waxman S J Cell Physiol; 1993 Oct; 157(1):90-6. PubMed ID: 8408246 [TBL] [Abstract][Full Text] [Related]
24. Retinoic acid receptor and retinoid X receptor expression in retinoic acid-resistant human tumor cell lines. van der Leede BM; van den Brink CE; van der Saag PT Mol Carcinog; 1993; 8(2):112-22. PubMed ID: 7691069 [TBL] [Abstract][Full Text] [Related]
25. Overexpression of the cellular retinoic acid binding protein-I (CRABP-I) results in a reduction in differentiation-specific gene expression in F9 teratocarcinoma cells. Boylan JF; Gudas LJ J Cell Biol; 1991 Mar; 112(5):965-79. PubMed ID: 1847931 [TBL] [Abstract][Full Text] [Related]
26. Genomic footprinting of retinoic acid regulated promoters in embryonal carcinoma cells. Dey A; Ozato K Methods; 1997 Feb; 11(2):197-204. PubMed ID: 8993032 [TBL] [Abstract][Full Text] [Related]
27. Cell fate specification in an in vitro model of neural development. Jostock R; Rentrop M; Maelicke A Eur J Cell Biol; 1998 May; 76(1):63-76. PubMed ID: 9650784 [TBL] [Abstract][Full Text] [Related]
28. Loss of retinoic acid receptor gamma function in F9 cells by gene disruption results in aberrant Hoxa-1 expression and differentiation upon retinoic acid treatment. Boylan JF; Lohnes D; Taneja R; Chambon P; Gudas LJ Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9601-5. PubMed ID: 8105479 [TBL] [Abstract][Full Text] [Related]
29. Differentially expressed isoforms of the mouse retinoic acid receptor beta generated by usage of two promoters and alternative splicing. Zelent A; Mendelsohn C; Kastner P; Krust A; Garnier JM; Ruffenach F; Leroy P; Chambon P EMBO J; 1991 Jan; 10(1):71-81. PubMed ID: 1846599 [TBL] [Abstract][Full Text] [Related]
31. Different response to retinoic acid of two teratocarcinoma cell lines. Wan YJ; Wang L; Wu TC Exp Cell Res; 1995 Aug; 219(2):392-8. PubMed ID: 7543852 [TBL] [Abstract][Full Text] [Related]
32. Transcriptional control of c-jun by retinoic acid. de Groot RP; Pals C; Kruijer W Nucleic Acids Res; 1991 Apr; 19(7):1585-91. PubMed ID: 1851295 [TBL] [Abstract][Full Text] [Related]
33. Differential capacity of wild type promoter elements for binding and trans-activation by retinoic acid and thyroid hormone receptors. Williams GR; Harney JW; Moore DD; Larsen PR; Brent GA Mol Endocrinol; 1992 Oct; 6(10):1527-37. PubMed ID: 1333048 [TBL] [Abstract][Full Text] [Related]
34. Demethylation in the 5'-flanking region of mouse cellular retinoic acid binding protein-I gene is associated with its high level of expression in mouse embryos and facilitates its induction by retinoic acid in P19 embryonal carcinoma cells. Wei LN; Lee CH Dev Dyn; 1994 Sep; 201(1):1-10. PubMed ID: 7528580 [TBL] [Abstract][Full Text] [Related]
36. Mouse cellular retinoic acid binding protein: cloning, complementary DNA sequence, and messenger RNA expression during the retinoic acid-induced differentiation of F9 wild type and RA-3-10 mutant teratocarcinoma cells. Stoner CM; Gudas LJ Cancer Res; 1989 Mar; 49(6):1497-504. PubMed ID: 2538228 [TBL] [Abstract][Full Text] [Related]
37. Expression of nuclear retinoic acid receptors in wild-type and mutant embryonal carcinoma PCC4.aza1R cells. Nervi C; Vollberg TM; Grippo JF; Lucas DA; George MD; Sherman MI; Shudo K; Jetten AM Cell Growth Differ; 1990 Nov; 1(11):535-42. PubMed ID: 1965138 [TBL] [Abstract][Full Text] [Related]
38. Dominant negative retinoic acid receptor beta. Shen S; van der Saag PT; Kruijer W Mech Dev; 1993 Mar; 40(3):177-89. PubMed ID: 8388240 [TBL] [Abstract][Full Text] [Related]
39. Different ligand responsiveness of human retinoic-acid-receptor beta-gene transcription in tumorigenic and non-tumorigenic cervical-carcinoma-derived cell lines is mediated through a large retinoic-acid-response domain. Baust C; Redpath L; Schwarz E Int J Cancer; 1996 Jul; 67(3):409-16. PubMed ID: 8707417 [TBL] [Abstract][Full Text] [Related]
40. Increased expression of c-jun, but not retinoic acid receptor beta, is associated with F9 teratocarcinoma stem cell differentiation induced by polyamine depletion. Bjersing JL; Brorsson A; Heby O J Cell Biochem; 1997 Dec; 67(3):378-85. PubMed ID: 9361192 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]